217 related articles for article (PubMed ID: 34919440)
1. The role of
Wang W; Ni X; Tang T; Wang J; Li Y; Song X
Br J Radiol; 2022 Feb; 95(1130):20210635. PubMed ID: 34919440
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary mucosa-associated lymphoid tissue lymphoma:
Albano D; Borghesi A; Bosio G; Bertoli M; Maroldi R; Giubbini R; Bertagna F
Br J Radiol; 2017 Nov; 90(1079):20170311. PubMed ID: 28830222
[TBL] [Abstract][Full Text] [Related]
3. Correlation between
Zhao J; Wang H
J Med Imaging Radiat Oncol; 2021 Apr; 65(2):188-194. PubMed ID: 33538120
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of 18F-FDG PET/CT for evaluating response of ocular adnexal lymphoma to treatment.
Fujii H; Tanaka H; Nomoto Y; Harata N; Oota S; Isogai J; Yoshida K
Medicine (Baltimore); 2018 Apr; 97(17):e0543. PubMed ID: 29703034
[TBL] [Abstract][Full Text] [Related]
5. Role of F-18 FDG PET/CT in non-conjunctival origin ocular adnexal mucosa-associated lymphoid tissue (MALT) lymphomas.
Park HL; O JH; Park SY; Jung SE; Park G; Choi BO; Kim SH; Jeon YW; Cho SG; Yang SW;
EJNMMI Res; 2019 Nov; 9(1):99. PubMed ID: 31754896
[TBL] [Abstract][Full Text] [Related]
6. 18F-FDG PET/CT in gastric MALT lymphoma: a bicentric experience.
Albano D; Bertoli M; Ferro P; Fallanca F; Gianolli L; Picchio M; Giubbini R; Bertagna F
Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):589-597. PubMed ID: 27619357
[TBL] [Abstract][Full Text] [Related]
7. Value of 18FDG PET scan in staging of ocular adnexal lymphomas: a large single-center experience.
Zanni M; Moulin-Romsee G; Servois V; Validire P; Bénamor M; Plancher C; Rouic LL; Dendale R; Vincent-Salomon A; Asselain B; Sahli R; Decaudin D
Hematology; 2012 Mar; 17(2):76-84. PubMed ID: 22664045
[TBL] [Abstract][Full Text] [Related]
8. Prognostic role of baseline
Albano D; Bosio G; Camoni L; Farina M; Re A; Tucci A; Giubbini R; Bertagna F
Hematol Oncol; 2019 Feb; 37(1):39-46. PubMed ID: 30299563
[TBL] [Abstract][Full Text] [Related]
9. Can Interim 18F-FDG PET or Diffusion-Weighted MRI Predict End-of-Treatment Outcome in FDG-Avid MALT Lymphoma After Rituximab-Based Therapy?: A Preliminary Study in 15 Patients.
Mayerhoefer ME; Karanikas G; Kletter K; Kiesewetter B; Weber M; Rausch I; Pones M; Simonitsch-Klupp I; Müllauer L; Dolak W; Lukas J; Raderer M
Clin Nucl Med; 2016 Nov; 41(11):837-843. PubMed ID: 27648705
[TBL] [Abstract][Full Text] [Related]
10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
11. 18F-FDG PET/CT in splenic marginal zone lymphoma.
Albano D; Giubbini R; Bertagna F
Abdom Radiol (NY); 2018 Oct; 43(10):2721-2727. PubMed ID: 29500652
[TBL] [Abstract][Full Text] [Related]
12. 18F-FDG uptake and its clinical relevance in primary gastric lymphoma.
Yi JH; Kim SJ; Choi JY; Ko YH; Kim BT; Kim WS
Hematol Oncol; 2010 Jun; 28(2):57-61. PubMed ID: 19593742
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of SUVmax measured by pretreatment 18F-FDG PET/CT in patients with primary gastric lymphoma.
Hwang JP; Lim I; Byun BH; Kim BI; Choi CW; Lim SM
Nucl Med Commun; 2016 Dec; 37(12):1267-1272. PubMed ID: 27482643
[TBL] [Abstract][Full Text] [Related]
14. Clinical and pathological predictors for FDG-PET/CT avidity in patients with marginal zone lymphoma-a retrospective cohort study.
Kagan KBT; Guz D; Buchrits S; Gurion R; Vaxman I; Priss M; Groshar D; Catalano OA; Sherban A; Raanani P; Gafter-Gvili A; Bernstine H
Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2290-2299. PubMed ID: 35079846
[TBL] [Abstract][Full Text] [Related]
15. The role of baseline 2-[
Albano D; Calabrò A; Dondi F; Bagnasco S; Tucci A; Bertagna F
Hematol Oncol; 2024 Mar; 42(2):e3266. PubMed ID: 38444261
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Positron Emission Tomography/Computed Tomography in Gastric Mucosa-associated Lymphoid Tissue Lymphoma.
Hwang JW; Jee SR; Lee SH; Kim JH; Seol SY; Lee SM
Korean J Gastroenterol; 2016 Apr; 67(4):183-8. PubMed ID: 27112244
[TBL] [Abstract][Full Text] [Related]
17. Role in staging and prognostic value of pretherapeutic F-18 FDG PET/CT in patients with gastric MALT lymphoma without high-grade transformation.
Park YJ; Hyun SH; Moon SH; Lee KH; Min BH; Lee JH; Kim WS; Kim SJ; Choi JY
Sci Rep; 2021 Apr; 11(1):9243. PubMed ID: 33927319
[TBL] [Abstract][Full Text] [Related]
18. 18F-FDG PET/CT for staging and response assessment of primary parotid MALT lymphoma with multiple sites involvement: A case report.
Ren Y; Huang L; Han Y; Cui Z; Li J; Dong C; Liu J
Medicine (Baltimore); 2019 Feb; 98(5):e14270. PubMed ID: 30702589
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary mucosa-associated lymphoid tissue lymphoma: computed tomography and ¹⁸F fluorodeoxyglucose-positron emission tomography/computed tomography imaging findings and follow-up.
Zhang WD; Guan YB; Li CX; Huang XB; Zhang FJ
J Comput Assist Tomogr; 2011; 35(5):608-13. PubMed ID: 21926857
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDG PET/CT and extragastric MALT lymphoma: role of Ki-67 score and plasmacytic differentiation.
Albano D; Bosio G; Giubbini R; Bertagna F
Leuk Lymphoma; 2017 Oct; 58(10):2328-2334. PubMed ID: 28270020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
